PortfoliosLab logo
SPG vs. NVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SPG and NVS is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

SPG vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Simon Property Group, Inc. (SPG) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

1,000.00%1,500.00%2,000.00%NovemberDecember2025FebruaryMarchApril
1,950.77%
787.44%
SPG
NVS

Key characteristics

Sharpe Ratio

SPG:

0.55

NVS:

1.01

Sortino Ratio

SPG:

0.89

NVS:

1.43

Omega Ratio

SPG:

1.12

NVS:

1.20

Calmar Ratio

SPG:

0.60

NVS:

0.97

Martin Ratio

SPG:

2.32

NVS:

2.11

Ulcer Index

SPG:

6.25%

NVS:

9.21%

Daily Std Dev

SPG:

26.55%

NVS:

19.17%

Max Drawdown

SPG:

-77.00%

NVS:

-41.72%

Current Drawdown

SPG:

-15.54%

NVS:

-3.90%

Fundamentals

Market Cap

SPG:

$58.88B

NVS:

$219.57B

EPS

SPG:

$7.27

NVS:

$5.87

PE Ratio

SPG:

21.49

NVS:

18.94

PEG Ratio

SPG:

4.44

NVS:

1.30

PS Ratio

SPG:

9.87

NVS:

4.25

PB Ratio

SPG:

17.24

NVS:

4.99

Total Revenue (TTM)

SPG:

$4.52B

NVS:

$39.24B

Gross Profit (TTM)

SPG:

$3.48B

NVS:

$29.47B

EBITDA (TTM)

SPG:

$3.32B

NVS:

$16.05B

Returns By Period

In the year-to-date period, SPG achieves a -7.90% return, which is significantly lower than NVS's 19.39% return. Over the past 10 years, SPG has underperformed NVS with an annualized return of 3.20%, while NVS has yielded a comparatively higher 6.70% annualized return.


SPG

YTD

-7.90%

1M

-7.00%

6M

-5.91%

1Y

15.33%

5Y*

32.28%

10Y*

3.20%

NVS

YTD

19.39%

1M

1.82%

6M

2.10%

1Y

17.28%

5Y*

10.29%

10Y*

6.70%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SPG vs. NVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SPG
The Risk-Adjusted Performance Rank of SPG is 7070
Overall Rank
The Sharpe Ratio Rank of SPG is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of SPG is 6363
Sortino Ratio Rank
The Omega Ratio Rank of SPG is 6464
Omega Ratio Rank
The Calmar Ratio Rank of SPG is 7676
Calmar Ratio Rank
The Martin Ratio Rank of SPG is 7676
Martin Ratio Rank

NVS
The Risk-Adjusted Performance Rank of NVS is 7979
Overall Rank
The Sharpe Ratio Rank of NVS is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 7676
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 7777
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 8484
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SPG vs. NVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Simon Property Group, Inc. (SPG) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for SPG, currently valued at 0.55, compared to the broader market-2.00-1.000.001.002.003.00
SPG: 0.55
NVS: 1.01
The chart of Sortino ratio for SPG, currently valued at 0.89, compared to the broader market-6.00-4.00-2.000.002.004.00
SPG: 0.89
NVS: 1.43
The chart of Omega ratio for SPG, currently valued at 1.12, compared to the broader market0.501.001.502.00
SPG: 1.12
NVS: 1.20
The chart of Calmar ratio for SPG, currently valued at 0.60, compared to the broader market0.001.002.003.004.005.00
SPG: 0.60
NVS: 0.97
The chart of Martin ratio for SPG, currently valued at 2.32, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
SPG: 2.32
NVS: 2.11

The current SPG Sharpe Ratio is 0.55, which is lower than the NVS Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of SPG and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.55
1.01
SPG
NVS

Dividends

SPG vs. NVS - Dividend Comparison

SPG's dividend yield for the trailing twelve months is around 5.27%, more than NVS's 3.56% yield.


TTM20242023202220212020201920182017201620152014
SPG
Simon Property Group, Inc.
5.27%4.70%5.22%5.87%3.66%7.04%5.57%4.70%4.16%3.66%3.11%2.74%
NVS
Novartis AG
3.56%3.84%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%

Drawdowns

SPG vs. NVS - Drawdown Comparison

The maximum SPG drawdown since its inception was -77.00%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for SPG and NVS. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-15.54%
-3.90%
SPG
NVS

Volatility

SPG vs. NVS - Volatility Comparison

Simon Property Group, Inc. (SPG) has a higher volatility of 16.61% compared to Novartis AG (NVS) at 9.15%. This indicates that SPG's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%NovemberDecember2025FebruaryMarchApril
16.61%
9.15%
SPG
NVS

Financials

SPG vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between Simon Property Group, Inc. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items